Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Caraglia

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Current Cancer Drug Targets|January 25, 2012
Editorial: target therapy in brain tumours and metastasesM Caraglia, R Addeo
Amino Acids|March 31, 2012
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclinsP Torricelli, M Caraglia, A Abbruzzese, et al.
Advances in Experimental Medicine and Biology|March 29, 2000
Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapyM Caraglia, P Tagliaferri, A Budillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2006
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone lossD Santini, B Vincenzi, M Caraglia, et al.
Current Drug Targets|April 29, 2005
Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylaseA Budillon, F Bruzzese, E Di Gennaro, et al.
Amino Acids|August 4, 2004
Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review articleA Lentini, A Abbruzzese, M Caraglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Phase II studies of anticancer chemotherapy: indirect evidence of poor qualityA Ottaiano, G Facchini, G Nasti, et al.
Amino Acids|August 4, 2004
Acetylation of proteins as novel target for antitumor therapy: review articleE Di Gennaro, F Bruzzese, M Caraglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2007
A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncologyA Ottaiano, A Budillon, N Normanno, et al.
Amino Acids|August 4, 2004
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review articleA Lamberti, M Caraglia, O Longo, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Current Cancer Drug Targets|January 25, 2012
Editorial: target therapy in brain tumours and metastasesM Caraglia, R Addeo
Amino Acids|March 31, 2012
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclinsP Torricelli, M Caraglia, A Abbruzzese, et al.
Advances in Experimental Medicine and Biology|March 29, 2000
Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapyM Caraglia, P Tagliaferri, A Budillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2006
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone lossD Santini, B Vincenzi, M Caraglia, et al.
Current Drug Targets|April 29, 2005
Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylaseA Budillon, F Bruzzese, E Di Gennaro, et al.
Amino Acids|August 4, 2004
Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review articleA Lentini, A Abbruzzese, M Caraglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Phase II studies of anticancer chemotherapy: indirect evidence of poor qualityA Ottaiano, G Facchini, G Nasti, et al.
Amino Acids|August 4, 2004
Acetylation of proteins as novel target for antitumor therapy: review articleE Di Gennaro, F Bruzzese, M Caraglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2007
A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncologyA Ottaiano, A Budillon, N Normanno, et al.
Amino Acids|August 4, 2004
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review articleA Lamberti, M Caraglia, O Longo, et al.
Pageof 13